|
It was reported that the patient experienced a low blood glucose event while sleeping, with a lowest value of 50 mg/dl, and was using the ilet pump; the patient received rapid-acting carbohydrates by mouth administered by another person after an urgent low alert and a rapid drop following prior pump-driven corrections and a subsequent pump pause and resume.Symptoms included hypoglycemia, loss of consciousness, sleepiness, confusion, irritability, lethargy, and vomiting.Outcomes included unexpected medication intervention and a serious injury or illness.Investigation included communication and interviews with the patient and analysis of information provided by the user or third party.The ilet bionic pancreas system user guide (ifu) was reviewed as part of the investigation.Section 4.5.3 of the ifu was found to include instructions and/or warnings relevant to the reported event.No deficiencies in the ifu that would have contributed to the complaint were identified.Investigation of this case revealed no findings available and insufficient information regarding a specific medical device problem or component.It was concluded, based on previously established findings for similar reports, that the cause was not established.
|